2LUNG CANCER STUDY GROUP. Randomized trial of lobectomy versus limited resection for T1N0 non--small cell lung cancer[J].Ann Thorac Surg, 1995, 60: 615--623.
3NARUKE T,SUEMASU K, ISHIKAWA S, et al. Lymph node mapping and curability of various levels of metastases in resected lung cancer[J]. J Thorac Cardiovasc Surg,1978, 76:832--839 .
4MCKENNA R J. Lobectomy by video--assisted thoracic surgery with mediastinal node sampling for lung cancer[J]. J Thorac Cardiovasc Surg, 1994,107:879--882.
6WU Y, HUANG Z, WANG S, et al. A randomized trial of systematlc nodal dissection in resectable non--small cell lung cancer[J]. Lung Cancer, 2002,36(1):1--6.
7Miller AB,Hoogatratem B,Staquet M,et al.Repeating result of cancer treatment[J].Cancer,1981,47(1):207.
8Shinkai T,Saijo N,Tominaga K,et al.Comparison of vindesine plus cisplatin or vindesine plus mitomycin in the treatment of advanced non-small cell lung cancer[J].Cancer Treat Rev,1985,69:945-951.
9Sorenser JB,Osterrad K,Hansen HH.Vinca alkaloids in the treatment of non-small cell lung cancer[J].Cancer Treat Rev,1987,14:59-51.
10Cirom CG,Ordonez A,Jblon JL,et al.Combination chemotherapy with ifosfamide,mitomycin C and cisplatin in advanced non-small cell lung cancer[J].Cancer Treat Rep,1987,71:85.
